Global In-Vitro Diagnostics (IVD) Market to 2020 - Industry Trends, Market Size, Segments, Growth Prospects

GrandViewResearch's picture
Printer-friendly versionPrinter-friendly versionPDF versionPDF version

Increasing demand for laboratory and point of care testing, due to growing prevalence of infectious diseases and geriatric population base, is expected to drive the market


San Francisco, California, USA., March 5, 2014 - (PressReleasePoint) -
The global market for IVD is expected to reach USD 74.32 billion by 2020, according to a new study by Grand View Research, Inc. Constantly improving patient awareness levels pertaining to infectious diseases and their subsequent diagnosis, the introduction of advanced molecular and tissue diagnostic tests for cancer such as companion diagnostics and the growing global base of geriatric population are some of the primary drivers for this market. Moreover, rising global healthcare expenditures, especially in Asia Pacific and increasing demand for rapid, minimally invasive and non-invasive diagnostic procedures are also expected to have a positive impact on market growth. The emergence of epigenomics-based diagnostics and the ability of molecular diagnostics to detect disease at an early stage of development are expected to create opportunity for industry participants to capitalize on over the next six years.
 
The professional diagnostic products dominated the overall IVD market in 2013, owing to the high usage rates of these tests in diagnostic tests pertaining to the infectious disease segment, and are expected to grow at a CAGR of 4.7% from 2014 to 2020 to reach an estimated value of USD 49.76 billion by 2020. However, the tissue diagnostics market is expected to grow at the highest CAGR of 10.2% from 2014 to 2020, owing to its growing application in cancer diagnosis and need for lab automation as a consequence of limited skilled labor availability.
 
The report “In-Vitro Diagnostics (IVD) Market Analysis And Segment Forecasts To 2020,” is available now to Grand View Research customers and can also be purchased directly at http://www.grandviewresearch.com/industry-analysis/in-vitro-diagnostics-ivd-market
 
Further Key findings from the study suggest:

  • North America is expected to dominate the overall market throughout the forecast period, majorly on account of the presence of sophisticated healthcare infrastructure, high patient awareness levels and improving reimbursement frameworks, with revenue estimated to reach USD 28.79 billion by 2020.
  • Asia Pacific is expected to be the fastest growing regional market for IVD, at an estimated CAGR of 7.4% from 2014 to 2020. The presence of high unmet medical needs for cancer and infectious diseases and a constantly improving healthcare infrastructure in emerging markets such as China and India are some of the drivers of this market.
  • The global molecular diagnostics market is expected to follow the tissue diagnostics segment in terms of growth during the forecast period, owing to the growing demand for advanced genetic and HPV diagnostic tests. Its market is expected to grow at a CAGR of 8.7% from 2014 to 2020.
  • Some of the key players of this market include Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, bioMerieux, Beckman Coulter Inc., Becton Dickinson and others

 
For the purpose of this study, Grand View Research has segmented the global IVD market on the basis of product and region:
IVD Market Product Outlook
Molecular Diagnostics
Tissue Diagnostics
Diabetes Monitoring
Professional Diagnostics
IVD Market Regional Outlook              
North America     
Europe     
Asia Pacific
RoW
 
About Grand View Research
 
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights. For more information, visit http://www.grandviewresearch.com/
 
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email:  sales@grandviewresearch.com


Press Contact:
1-415-349-0058
28 2nd Street, Suite 3036
San Francisco, CA 94105
United States
1-415-349-0058
http://www.grandviewresearch.com/
***@*r**d**e**e**a**h.com
Email partially hidden to block spam. Please use the contact form here.
Contact 1-415-349-0058
Email the contact person for this press release. Do not send spam or irrelevant message.
9 + 7 =


Copy this html code to your website/blog to embed this press release.

Comments

Post new comment

2 + 0 =